Form 4: HCA Healthcare Executive Sowell Exercises Stock Appreciation Rights
SEC Form 4 Filing
Joseph A. Sowell III, SVP and Chief Development Officer of HCA Healthcare, exercised stock appreciation rights and disposed of shares to cover tax obligations.
Summary
- On May 15, 2024, Joseph A. Sowell III, SVP and Chief Development Officer of HCA Healthcare, exercised stock appreciation rights.
- This involved the acquisition of 19,000 shares of common stock at a price of $68.96.
- Simultaneously, Sowell disposed of 9,908 shares to satisfy tax obligations at a price of $326.96.
- Following these transactions, Sowell directly owns 13,367 shares and indirectly owns 29,771 shares through a spouse trust, 5,159 shares through a 2023 trust, and 8,000 shares through a trust where he is the trustee.
- The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing an executive's stock transactions, which is neutral in sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.
Comparison to Industry Standards
- Executive compensation packages often include stock options and appreciation rights to align management's interests with those of shareholders.
- The vesting schedule and terms of these rights are generally comparable to those offered by peer companies in the healthcare industry.
- Companies like Universal Health Services (UHS) and Tenet Healthcare (THC) also utilize similar equity-based compensation strategies for their executives.
Stakeholder Impact
- The transaction has a minimal direct impact on shareholders, as it is a routine executive stock transaction.
- It provides transparency into executive compensation and alignment with company performance.
Key Dates
| Date | Description |
|---|---|
| 2009-12-10 | Date of Power of Attorney execution. |
| 2016-02-04 | Start date of vesting for stock appreciation rights in four equal annual installments. |
| 2024-05-15 | Date of transaction: exercise of stock appreciation rights and disposal of shares. |
| 2024-05-17 | Date of signature for the Form 4 filing. |
| 2025-02-04 | Expiration date of the stock appreciation rights. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.